Observational Study of the Efficacy and Safety of Anlotinib Combined With Penpulimab in Elderly Lung Cancer Patients

NCT05319886 · clinicaltrials.gov ↗

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Lung Carcinoma
Non Small Cell Lung Cancer
Non-small Cell Carcinoma
Lung Neoplasm

Interventions

DRUG: Anlotinib and Penpulimab

Sponsor

The First Affiliated Hospital of Xinxiang Medical College